https://www.selleckchem.com/pr....oducts/stf-083010.ht
Point prevalence was 181.8 per 100,000 (95% CI 156.5-207.1) in 2015. The percentage of females increased from 39% in 1970-1999 and 41% in 2000-2009 to 54% in 2010-2017 (p=0.08). Overall survival in PsA did not differ from general population (SMR= 0.85, 95% CI 0.61-1.15). The incidence of PsA in this predominantly white US population was stable in 2000-2017 in contrast to previous years. However, an increasing proportion of females was found in this study. The incidence of PsA in this predominantly white US population was stable in 20
Curtir
Comentario
Compartilhar
